http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S6217655-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f97f0fa258a008bf056ad04b7f380dda
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-06
filingDate 1985-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ba33f0298974eb3a92941d4b1425717
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd2eaa3885588c323850cc3c02746bda
publicationDate 1987-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-S6217655-A
titleOfInvention Method and apparatus for analyzing lidocaine in blood
abstract PURPOSE: To facilitate automation and to shorten the analytical time of a specimen, by directly injecting serum in a high performance liquid chromatography to perform the separation and quantification of lidocaine in blood. n CONSTITUTION: An analytical apparatus 1 is equipped with the flow line 7 of a phosphate buffer solution as a first mobile phase, the flow line 8 of a second mobile phase 4, pretreatment column 5 comprising tetramethylolmethane triacrylate resin, the flow line 13 for the pretreatment column and the analytical flow line 6 to a separation column 10 and these elements are connected so as to be capable of being changed over by a six-way valve 6. Serum being a specimen is introduced into the column 5 comprising a polymethylolalkane polyacrylate resin by using the buffer solution 2 with pH5W12 containing a poplar org. solvent as the first mobile phase to together trap lidocaine and a protein component. Next, lidocaine is eluted by using a buffer solution with pH5 or less containing a polar org. solvent as the second mobile phase 4 and the eluate is subjected to a high performance liquid chromatography to perform the analysis of lidocaine. n COPYRIGHT: (C)1987,JPO&Japio
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H04266783-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106248819-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H01250858-A
priorityDate 1985-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3676
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414885125
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406004
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19042
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555252

Total number of triples: 24.